Results 111 to 120 of about 163,168 (216)
A novel mutation leading to a deletion in the SH3 domain of Bruton's tyrosine kinase
X-linked agammaglobulinemia (XLA) is a primary B cell immunodeficiency disorder, caused by a defect in the Bruton tyrosine kinase (BTK) gene. Here, we describe a novel four base pair mutation (838delGAGT) in intron 9 of the BTK gene leading to the
Lütfiye Mesci +5 more
doaj
Drug reaction to ceftriaxone in a child with X-linked agammaglobulinemia [PDF]
Vandana Kudva-Patel +4 more
openalex +1 more source
X-linked agammaglobulinemia – A rare but treatable disorder
Dr. Rajesh Kunchelikar +3 more
doaj +1 more source
Background X-linked agammaglobulinemia (XLA) is an inborn error of immunity resulting from mutations in the BTK gene. It is an X-linked inherited disease that almost exclusively affects males, while females are usually carriers of the disease.
Sundus M. NoorSaeed +4 more
doaj +1 more source
Clinical Manifestations and Treatment in Korean Patients with X-Linked Agammaglobulinemia [PDF]
Hanna Cho, Joong Gon Kim
openalex +1 more source
Genetic Analysis of Familial X-Linked Agammaglobulinemia [PDF]
Wei Guan +5 more
openalex +1 more source
695. Splice-Correction of X-Linked Agammaglobulinemia in a Human BAC-Transgenic Mouse Model Using Oligonucleotides [PDF]
Burcu Bestas +8 more
openalex +1 more source
X-linked ammaglobulinemia complicated with renal injury: one case report
Ya-mei Hai +3 more
doaj +1 more source
Monoclonal Antibodies for COVID-19 in X-linked Agammaglobulinemia: a Case Series. [PDF]
Simard ML +4 more
europepmc +1 more source

